AI
PHGE icon

Allostery Investments’s BiomX PHGE Stock Holding History

Allostery Investments’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49,507
Closed -$523K – 35
2025
Q1 		$523K Buy
49,507
+15,621
+46% +$218K 0.75% 28
2024
Q4 		$470K Buy
+33,886
New +$483K 0.49% 32

Other funds holding PHGE

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Allostery Investments's PHGE Position: Q2 2025 in Review

Allostery Investments sold out of BiomX (PHGE) in Q2 2025, closing a stake of 49,507 shares — an estimated $523K sold.

Allostery Investments first reported a position in PHGE in Q4 2024 and held it in 2 quarters. The position peaked at $523K in Q1 2025. 18 funds tracked by Wall St. Rank hold PHGE as of Q2 2025.

  • Allostery Investments reported no remaining BiomX position as of Q2 2025 after selling out during the quarter.
  • Allostery Investments sold 49,507 BiomX shares in Q2 2025, an estimated $523K.
  • Allostery Investments first reported a position in BiomX in Q4 2024 and held it in 2 quarters.
  • Allostery Investments's BiomX position peaked at $523K in Q1 2025.
  • 18 funds tracked by Wall St. Rank held BiomX as of Q2 2025.

Based on Allostery Investments's 13F filing for Q2 2025, filed 14 Aug 2025.